5 medicines held by Sun Phamaceutical Industries Europe B.V. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Atosiban SUN 37.5 mg/5 ml concentrate for solution for infusion EU/1/13/852/002 |
Atosiban | Sun Phamaceutical Industries Europe B.V. | — |
| Atosiban SUN 6.75 mg/0.9 ml solution for injection EU/1/13/852/001 |
Atosiban | Sun Phamaceutical Industries Europe B.V. | — |
| Bortezomib SUN 3.5 mg powder for solution for injection EU/1/16/1102/001 |
Bortezomib | Sun Phamaceutical Industries Europe B.V. | — |
| Levetiracetam SUN 100 mg/ml concentrate for solution for infusion EU/1/11/741/001 |
Levetiracetam | Sun Phamaceutical Industries Europe B.V. | — |
| Teriparatide SUN 20 micrograms/80 microliters solution for injection in pre-filled pen EU/1/22/1697/001-002 |
Teriparatide | Sun Phamaceutical Industries Europe B.V. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 22 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.